Organ- and Cell-Selective Delivery of mRNA In Vivo Using Guanidinylated Serinol Charge-Altering Releasable Transporters
Journal of the American Chemical Society · 29.05.2024 · 146 (21) · 14785-14798
DOI: 10.1021/jacs.4c02704 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 14.05.2024. Verfasst von Zhijian Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Stanford University, Stanford, California 94305, United States. Hauptthemen laut MEDLINE: RNA, Messenger, Guanidine. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Howard Hughes Medical Institute, Emerson Collective.
Abstract (Originalsprache)
Selective RNA delivery is required for the broad implementation of RNA clinical applications, including prophylactic and therapeutic vaccinations, immunotherapies for cancer, and genome editing. Current polyanion delivery relies heavily on cationic amines, while cationic guanidinium systems have received limited attention due in part to their strong polyanion association, which impedes intracellular polyanion release. Here, we disclose a general solution to this problem in which cationic guanidinium groups are used to form stable RNA complexes upon formulation but at physiological pH undergo a novel charge-neutralization process, resulting in RNA release. This new delivery system consists of guanidinylated serinol moieties incorporated into a charge-altering releasable transporter (GSer-CARTs). Significantly, systematic variations in structure and formulation resulted in GSer-CARTs that exhibit highly selective mRNA delivery to the lung (∼97%) and spleen (∼98%) without targeting ligands. Illustrative of their breadth and translational potential, GSer-CARTs deliver circRNA, providing the basis for a cancer vaccination strategy, which in a murine model resulted in antigen-specific immune responses and effective suppression of established tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Stanford University, Stanford, California 94305, United States.
- Center for Personal Dynamic Regulomes, Stanford University, Stanford, California 94305, United States.
- Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California 94305, United States.
- Department of Materials Science & Engineering, Stanford University, Stanford, California 94305, United States.
- Department of Ophthalmology, Stanford University School of Medicine, Stanford, California 94305, United States.
- Howard Hughes Medical Institute, Stanford University, Stanford, California 94305, United States.
ORCID-Profile: Zhijian Li, Laura Amaya, Alok Ranjan, Robert M Waymouth, Paul A Wender
Förderung
- NCI NIH HHS
- Howard Hughes Medical Institute
- Emerson Collective
- National Cancer Institute
- Stanford Bio-X
- Center for Molecular Analysis and Design, Stanford University
Zitieren
APA
Li, Z., Amaya, L., Ee, A., Wang, S. K., Ranjan, A., Waymouth, R. M., Chang, H. Y., & Wender, P. A. (2024). Organ- and Cell-Selective Delivery of mRNA In Vivo Using Guanidinylated Serinol Charge-Altering Releasable Transporters. Journal of the American Chemical Society, 146(21), 14785-14798. https://doi.org/10.1021/jacs.4c02704
Vancouver
Li Z, Amaya L, Ee A, Wang SK, Ranjan A, Waymouth RM, et al. Organ- and Cell-Selective Delivery of mRNA In Vivo Using Guanidinylated Serinol Charge-Altering Releasable Transporters. Journal of the American Chemical Society. 2024;146(21):14785-14798. doi:10.1021/jacs.4c02704
BibTeX
@article{Li2024,
author = {Li, Zhijian and Amaya, Laura and Ee, Aloysius and Wang, Sean K and Ranjan, Alok and Waymouth, Robert M and Chang, Howard Y and Wender, Paul A},
title = {Organ- and Cell-Selective Delivery of mRNA In Vivo Using Guanidinylated Serinol Charge-Altering Releasable Transporters},
journal = {Journal of the American Chemical Society},
year = {2024},
volume = {146},
number = {21},
pages = {14785--14798},
doi = {10.1021/jacs.4c02704}
}
EUVIMED